Research and Markets (http://www.researchandmarkets.com/research/590919/the_pharmaceutical)
has announced the addition of the "The
Pharmaceutical Market: Denmark" report to their offering.
This in-depth pharmaceutical market report is ideal for executives
wanting to understand the key drivers in pharmaceutical markets and have
access to a wealth of statistical data. Each report opens with an
outlook section that provides analysis of the market, 5-year market
forecasts, national data projections, market outlook and key
developments such as regulation, pricing/reimbursement, intellectual
property, health facilities and government policy. The report also
provides extensive background information, population trends, health
status, health expenditure, organisation & administration, hospital
services, medical personnel, healthcare development, market access
information, trade data for raw materials and finished products and
essential industry contacts. Included with the report are 3 free
quarterly updated outlook reports, enabling you to keep up to date with
market developments for a year.
Executive Summary
The size of the pharmaceutical market in Denmark is estimated to be
US$3.9 billion in 2009, equal to US$711 per capita. The primary care
sector constitutes nearly three quarters of the total market size. The
market is expected to expand by 8.0% per annum between 2009 and 2014. By
2014, the market is estimated to be worth US$6.4 billion, equal to
US$1,134 per capita.
Denmark has a stable political system and a stable economy. However,
Denmark is likely to be affected by the global economic downturn, with
GDP real growth expected to fall to -3.5% in 2009, according to figures
from the Economist Intelligence Unit, and gradually rising to reach a
real growth of 2.0% in 2014.
Due to the presence of Novo Nordisk, Denmark is a major global supplier
of insulin in retail form. This has resulted in a long-standing balance
of trade surplus, which was in excess of US$4.7 billion in 2008. Between
2004 and 2008, imports increased by a CAGR of 11.9% to US$3.2 billion,
while exports increased by a CAGR of 10.5% to US$7.9 billion.
Healthcare expenditure has continued its steady growth in the past few
years, increasing by 7.1% to reach DKK118.3 billion (US$21.7 billion) in
2007, with private expenditure accounting for around 16% of the total.